TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF‐κB signalling pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shaochang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, College of Life Sciences, Beijing Normal University, Beijing,…. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Chemokine CCL20, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology of Ministry of Education, the Beijing Nova Program.
Abstract (Originalsprache)
TH1L (also known as NELF‐C/D) is a member of the Negative Elongation Factor (NELF) complex, which is a metazoan‐specific factor that regulates RNA Polymerase II (RNAPII) pausing and transcription elongation. However, the function and molecular mechanisms of TH1L in cancer progression are still largely unknown. In this study, we found that TH1L was highly expressed in colorectal cancer (CRC) tissues and the faeces of CRC patients. Overexpression of TH1L significantly enhanced the proliferation and migration of CRC cells, while its knockdown markedly suppressed these processes. In mechanism, RNA sequencing revealed that CCL20 was upregulated in TH1L‐overexpressed CRC cells, leading to activation of the NF‐κB signalling pathway. Rescue assays showed that knockdown of CCL20 could impair the tumour‐promoting effects of THIL in CRC cells. Taken together, these results suggest that TH1L may play a vital role via the CCL20/NF‐κB signalling pathway in CRC proliferation and migration and may serve as a potential target for diagnosis and therapy of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, College of Life Sciences, Beijing Normal University, Beijing, China.
- Department of Laboratory Medicine, Peking University International Hospital, Beijing, China.
- Department of Cancer Precision Medicine, The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Gastroenterology, Beijing Friendship Hospital, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseas…
ORCID-Profile: Yu Shang
Förderung
- National Natural Science Foundation of China
- Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology of Ministry of Education
- the Beijing Nova Program
Zitieren
APA
Wang, S., Sun, Y., Li, C., Chong, Y., Ai, M., Wang, Y., Shi, H., & Shang, Y. (2024). TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF‐κB signalling pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18391
Vancouver
Wang S, Sun Y, Li C, Chong Y, Ai M, Wang Y, et al. TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF‐κB signalling pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18391
BibTeX
@article{Wang2024,
author = {Wang, Shaochang and Sun, Yujing and Li, Chunya and Chong, Yueyang and Ai, Meihong and Wang, Yanxia and Shi, Haiyun and Shang, Yu},
title = {TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF‐κB signalling pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18391}
}
EUVIMED